Repligen (RGEN) EBT (2010 - 2026)

Repligen (RGEN) has 17 years of EBT data on file, last reported at $1.8 million in Q1 2026.

• EBT for Q1 2026 came in at $1.8 million, down 77.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $56.2 million (up 346.68% YoY), and the FY2025 annual result was $62.4 million, up 330.75% from the prior year.
• EBT fell to $1.8 million in Q1 2026 per RGEN's latest filing, from $19.1 million in the prior quarter.
• Over five years, EBT peaked at $59.8 million in Q2 2022 and troughed at -$100.5 million in Q4 2022.
• A 5-year average of $9.4 million and a median of $11.4 million in 2023 frame the typical range for EBT.
• The sharpest annual moves came in 2024 and 2025: EBT plunged 2170.13% in 2024, then soared 1589.3% in 2025.
• A 5-year view of EBT shows it stood at -$100.5 million in 2022, then surged by 101.86% to $1.9 million in 2023, then sank by 2170.13% to -$38.6 million in 2024, then jumped by 149.51% to $19.1 million in 2025, then tumbled by 90.73% to $1.8 million in 2026.
• Business Quant data shows RGEN's EBT at $1.8 million in Q1 2026, $19.1 million in Q4 2025, and $17.1 million in Q3 2025.